Board of Directors

Our team brings together different disciplines to help make a positive difference to mental health. The more angles we can consider mental health from, the more we will see.

Ekaterina Malievskaia MD MScPH

Chief Innovation Officer and Co‑Founder

Focuses on evidence-based and effective mental health care

George Goldsmith

Chairman, Chief Executive Officer, and Co‑founder

Entrepreneur dedicated to bringing about positive change in society

Annalisa Jenkins MBBS

Independent Director

Annalisa is a senior biotech executive, the Executive Chairman at Vium and a Non-Executive Director at eight other biotech companies.

David Norton

Independent Director

David Norton is a senior Biopharma Executive, and the former Company Group Chairman of Global Pharmaceuticals at Johnson & Johnson.

Florian Brand

Member of Board of Directors and Founding Seed and Series A Investor

Florian is the Co-Founder and Chief Executive Officer of ATAI Life Sciences AG, a Seed and Series A investor in COMPASS.

Robert McQuade, Ph.D.

Independent Director

Bob is EVP and Chief Strategic Officer at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and President of the McQuade Center for Strategic Research and Development (MSRD)

Jason Camm

Independent Director

Managing Director and Chief Medical Officer at Thiel Capital LLC

Thomas Lönngren

Independent Director

Thomas Lönngren is a senior regulatory Executive, and served as Executive Director of the European Medicines Agency (EMA) from 2001-2010.

Our team brings together different disciplines to help make a positive difference to mental health. The more angles we can consider mental health from, the more we will see.

Meet our Scientific Advisory Board